U.S. CDC panel endorses Pfizer booster shot for elderly, high-risk people

A U.S. Centers for Disease Control and Prevention (CDC) advisory panel on Thursday endorsed booster doses of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with certain high risk conditions.

The panel voted 15-0 to recommend a booster dose for Americans age 65 and older and people in long term care facilities. It also fully recommended giving a single booster dose to people between the ages of 50 and 64 with certain high risk conditions, by a vote of 13-2.

On Wednesday, the Food and Drug Administration approved Pfizer boosters for people aged 65 and older or at high-risk. The extra dose would be given once they are at least six months past their last Pfizer shot.

CDC Director Rochelle Walensky is expected to accept the panel’s endorsement shortly. (Xinhua)-rir

Popular

PH passes 2027 ASEAN chairship to Singapore

By Dean Aubrey Caratiquet As the 49th ASEAN Summit drew to a close, President Ferdinand R. Marcos Jr. looked back at the priorities that the...

Trade, tourism take center stage at ASEAN-India Summit

By Dean Aubrey Caratiquet Moving beyond regional boundaries, ASEAN continues to build upon its relationship with India, which can create further opportunities for both parties. Spearheading...

ASEAN-Japan Summit focuses on energy, defense, cybersecurity, people-to-people exchanges

By Dean Aubrey Caratiquet Beyond building energy resiliency, the Philippines also expressed its interest to work with other member states in the areas of cybersecurity,...

Security, tech, trade among key highlights in ASEAN-ROK Summit

By Dean Aubrey Caratiquet Beyond culture and cuisine, South Korea’s contributions to the region continue to expand under the country’s partnership with the Association of...